IL88702A0 - Thioformamide derivatives - Google Patents

Thioformamide derivatives

Info

Publication number
IL88702A0
IL88702A0 IL88702A IL8870288A IL88702A0 IL 88702 A0 IL88702 A0 IL 88702A0 IL 88702 A IL88702 A IL 88702A IL 8870288 A IL8870288 A IL 8870288A IL 88702 A0 IL88702 A0 IL 88702A0
Authority
IL
Israel
Prior art keywords
optionally substituted
naphthylmethyl
alkyl
thioformamide derivatives
derivatives
Prior art date
Application number
IL88702A
Other languages
English (en)
Original Assignee
May & Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by May & Baker Ltd filed Critical May & Baker Ltd
Publication of IL88702A0 publication Critical patent/IL88702A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00—Thiocarboxylic acids
    • C07C327/38—Amides of thiocarboxylic acids
    • C07C327/46—Amides of thiocarboxylic acids having carbon atoms of thiocarboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Psychiatry (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Cold Air Circulating Systems And Constructional Details In Refrigerators (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL88702A 1987-12-18 1988-12-16 Thioformamide derivatives IL88702A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878729522A GB8729522D0 (en) 1987-12-18 1987-12-18 New compositions of matter

Publications (1)

Publication Number Publication Date
IL88702A0 true IL88702A0 (en) 1989-07-31

Family

ID=10628683

Family Applications (1)

Application Number Title Priority Date Filing Date
IL88702A IL88702A0 (en) 1987-12-18 1988-12-16 Thioformamide derivatives

Country Status (17)

Country Link
EP (1) EP0321273B1 (xx)
JP (1) JPH02273A (xx)
KR (1) KR890009866A (xx)
AT (1) ATE104661T1 (xx)
AU (1) AU2692988A (xx)
CA (1) CA1326485C (xx)
DE (1) DE3889208T2 (xx)
DK (1) DK702788A (xx)
ES (1) ES2054833T3 (xx)
FI (1) FI885839A (xx)
GB (1) GB8729522D0 (xx)
HU (1) HU201006B (xx)
IL (1) IL88702A0 (xx)
NZ (1) NZ227360A (xx)
OA (1) OA09024A (xx)
PT (1) PT89244B (xx)
ZA (1) ZA889420B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8913865D0 (en) * 1989-06-16 1989-08-02 May & Baker Ltd New compositions of matter
GB8907306D0 (en) * 1989-03-31 1989-05-17 May & Baker Ltd New compositions of matter
AU5712890A (en) * 1989-06-16 1990-12-20 Rhone-Poulenc Sante New thioformamide derivatives
GB9000342D0 (en) * 1990-01-08 1990-03-07 May & Baker Ltd New compositions of matter
JPH04211048A (ja) * 1990-03-05 1992-08-03 Mitsubishi Kasei Corp チオカルバモイルアセトニトリル誘導体
HUT66229A (en) * 1991-10-14 1994-10-28 Eisai Co Ltd Thioformamide derivatives and process for producing them and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
KR890009866A (ko) 1989-08-04
AU2692988A (en) 1989-06-22
DE3889208T2 (de) 1994-10-06
FI885839A (fi) 1989-06-19
OA09024A (en) 1991-03-31
PT89244A (pt) 1989-12-29
GB8729522D0 (en) 1988-02-03
JPH02273A (ja) 1990-01-05
EP0321273B1 (en) 1994-04-20
DK702788A (da) 1989-06-19
ATE104661T1 (de) 1994-05-15
EP0321273A2 (en) 1989-06-21
DE3889208D1 (de) 1994-05-26
CA1326485C (en) 1994-01-25
EP0321273A3 (en) 1989-10-04
FI885839A0 (fi) 1988-12-16
PT89244B (pt) 1993-07-30
ZA889420B (en) 1989-09-27
NZ227360A (en) 1990-09-26
DK702788D0 (da) 1988-12-16
HU201006B (en) 1990-09-28
HUT49117A (en) 1989-08-28
ES2054833T3 (es) 1994-08-16

Similar Documents

Publication Publication Date Title
FI906204A (fi) Menetelmä farmaseuttisesti vaikuttavien peptidiyhdisteiden valmistamiseksi
IE893653L (en) Compositions and compounds
DE3888806T2 (de) Thioformamidderivate.
EP0321273A3 (en) Thioformamide derivatives
AU656197B2 (en) Indolizinly testosterone 5 alpha-reductase inhibitors
DE68900990D1 (en) Thioformamid-derivate.
GB8515212D0 (en) Thiazolidine derivatives